Stockreport

BRIEF-Actobio Therapeutics Greenlighted By FDA To Commence A Phase Ib/Iia Trial With AG019 [Reuters]

INTREXON CORP  (XON) 
Last intrexon corp earnings: 11/12 07:30 am Check Earnings Report
US:NYSE Investor Relations: investors.dna.com
PDF BRIEF-Actobio Therapeutics Greenlighted By FDA To Commence A Phase Ib/Iia Trial With AG019 | Reuters Reuters Staff 1 Min Read March 29 (Reuters) - Intrexon Corp: * ACTOB [Read more]